News and Announcements
BPS Expands US Bartercard Operations by 50% in One Month
- Published September 27, 2016 2:47PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
26th September 2016, ASX Announcement
Highlights
- BPS continues to execute its Bartercard growth strategy in North America, opening six new franchises across the US in a record-breaking month
- Bartercard now has a presence in eight states which represent 25% of US economic output
- BPS is continuing to pursue a robust pipeline of potential US franchises
Leading financial technology platform provider BPS Technology Limited (ASX:BPS, “the Company”) is pleased to announce that it has continued to expand the reach of its Bartercard operations in North America.
In a record-breaking month of signings, BPS has just opened six new franchises across the US, growing the Company’s US business network to 18 franchises.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
